Affinage

AP5B1

AP-5 complex subunit beta-1 · UniProt Q2VPB7

Length
878 aa
Mass
93.9 kDa
Annotated
2026-06-09
30 papers in source corpus 7 papers cited in narrative 7 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

AP5B1 encodes the β subunit of AP-5, an evolutionarily ancient heterotetrameric adaptor protein complex that assembles in a stoichiometric (~1:1:1:1:1:1) complex with SPG11 and SPG15 on late endosomes/lysosomes and mediates retrieval of cargoes back to the Golgi (PMID:23825025). AP-5 functions as a backup to the retromer pathway: CRISPR knockout of an AP-5 subunit impairs retrieval of CIMPR, GOLIM4, and GOLM1 from endosomes to the Golgi, the phenotype is exacerbated by retromer knockdown, and CIMPR and sortilin bind the AP-5-associated protein SPG15 (PMID:29381698). Recruitment of the AP-5/SPG11/SPG15 complex to late endosomes/lysosomes requires coincidence detection of PI3P (via the SPG15 FYVE domain) and Rag GTPases, with GDP-locked RagC promoting and GTP-locked RagA preventing recruitment, and is enhanced upon starvation, linking the complex to the mTORC1 pathway (PMID:33464297). Loss of AP-5 function produces accumulation of aberrant multilamellar endolysosomal storage structures, defining AP-5 deficiency as a lysosomal storage disorder (PMID:26085577). Bi-allelic loss-of-function variants in AP5B1 cause recessive inherited macular dystrophy, with AP5B1 localizing to puncta marked by late endosome and Golgi markers in retinal pigment epithelium (PMID:40081374).

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 2013 High

    Established that AP-5 is not a free-standing adaptor but a stable partner of SPG11 and SPG15 acting in endosomal cargo sorting, answering what molecular assembly AP-5 belongs to and where it acts.

    Evidence Reciprocal co-immunoprecipitation, parallel siRNA knockdowns with CIMPR localization readout, in vitro pull-down, and subcellular fractionation

    PMID:23825025

    Open questions at the time
    • Did not define the directionality of the sorting step or the destination compartment
    • Specific contribution of the β subunit (AP5B1) versus other subunits not dissected
    • No structural model of the assembled complex
  2. 2015 High

    Connected AP-5 loss to a defined cellular pathology, showing that AP-5 deficiency produces multilamellar endolysosomal storage and constitutes a lysosomal storage disease.

    Evidence Patient-derived fibroblast ultrastructural analysis by electron microscopy plus siRNA knockdown in HeLa cells

    PMID:26085577

    Open questions at the time
    • The molecular cargo whose mistrafficking drives storage accumulation was not identified
    • Did not establish the trafficking step disrupted upstream of storage
  3. 2016 Medium

    Demonstrated that AP-5 serves a specific intracellular trafficking route exploited by HIV-2 Gag, distinguishing it from AP-1/AP-2/AP-3 requirements.

    Evidence siRNA knockdown of individual AP complexes with HIV-1/HIV-2 particle release assays

    PMID:27392064

    Open questions at the time
    • Single-lab result limited to a viral cargo context
    • The host trafficking step and direct cargo interaction were not defined
  4. 2018 High

    Defined the directionality and pathway context of AP-5, showing it mediates late endosome-to-Golgi retrieval of specific cargoes and acts as a backup to retromer.

    Evidence CRISPR-Cas9 knockout with quantitative mass spectrometry fractionation profiling, immunolocalization, pull-down, and retromer knockdown epistasis

    PMID:29381698

    Open questions at the time
    • Cargo recognition was attributed to SPG15 rather than to AP5B1 directly
    • How AP-5 is mechanistically coordinated with retromer was not resolved
  5. 2021 High

    Resolved how the AP-5/SPG11/SPG15 complex is recruited to membranes, identifying PI3P and Rag GTPase coincidence detection as the targeting mechanism and linking it to mTORC1/nutrient status.

    Evidence Live-cell imaging with PI3P manipulation, dominant-negative/constitutively active Rag GTPase mutants, and starvation experiments

    PMID:33464297

    Open questions at the time
    • The physical Rag GTPase contact surface on the complex was not mapped
    • The role of the β subunit in recruitment versus the SPG15 FYVE domain was not separated
  6. 2025 Medium

    Tied AP5B1 directly to human disease, showing bi-allelic loss-of-function variants cause recessive macular dystrophy and implicating AP-5 in RPE endolysosomal homeostasis.

    Evidence Whole-genome/exome sequencing across families plus immunostaining co-localizing AP5B1 with late endosome and Golgi markers in RPE cells

    PMID:40081374

    Open questions at the time
    • Cellular mechanism inferred from co-localization rather than direct functional assay in RPE
    • Why AP5B1 loss manifests in the macula specifically is unexplained

Open questions

Synthesis pass · forward-looking unresolved questions
  • How AP5B1 itself contributes to cargo selection, complex assembly, and membrane deformation within the AP-5 coat remains undefined.
  • No structure of the assembled AP-5 coat or the β subunit
  • Direct cargo-binding role of AP5B1 versus SPG15 not established
  • Mechanism linking endosome-to-Golgi retrieval failure to macular versus neuronal phenotypes unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2
Localization
GO:0005768 endosome 4 GO:0005764 lysosome 2 GO:0005794 Golgi apparatus 2
Pathway
R-HSA-5653656 Vesicle-mediated transport 2 R-HSA-9609507 Protein localization 1
Partners
Complex memberships
AP-5 adaptor complexAP-5/SPG11/SPG15 complex

Evidence

Reading pass · 7 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2013 AP-5 forms a stoichiometric (~1:1:1:1:1:1) complex with SPG11 and SPG15, co-immunoprecipitated from both cytosol and detergent-extracted membranes. Knockdowns of SPG11 or SPG15 phenocopy knockdowns of AP-5 subunits, all causing the cation-independent mannose 6-phosphate receptor (CIMPR) to become trapped in clusters of early endosomes. AP-5, SPG11, and SPG15 colocalize on a late endosomal/lysosomal compartment. The N-terminal β-propeller-like domain of SPG11 interacts in vitro with AP-5. Co-immunoprecipitation, siRNA knockdown with immunolocalization phenotype, in vitro pull-down, subcellular fractionation Molecular biology of the cell High 23825025
2018 AP-5 functions in a late endosome-to-Golgi retrieval pathway. CRISPR-Cas9 knockout of AP5Z1 in HeLa cells leads to impaired retrieval of CIMPR, GOLIM4, and GOLM1 from endosomes back to the Golgi. The retromer complex shows altered steady-state distribution in AP-5 KO cells, and retromer knockdown exacerbates the AP-5 KO phenotype, placing AP-5 as a backup pathway for retromer. Both CIMPR and sortilin interact with the AP-5-associated protein SPG15 in pull-down assays. CRISPR-Cas9 knockout, subcellular fractionation profiling with quantitative mass spectrometry, immunolocalization, pull-down assays, siRNA knockdown epistasis PLoS biology High 29381698
2015 Loss of AP-5 ζ protein (and reduction of AP-5 µ5) in patient-derived fibroblasts causes accumulation of abundant multilamellar endolysosomal structures filled with aberrant storage material (multilamellar whorls, striated belts, fingerprint bodies). This phenotype is replicated by siRNA knockdown of AP-5 ζ in HeLa cells, defining AP-5 deficiency as a new type of lysosomal storage disease. Patient-derived fibroblast characterization, ultrastructural analysis (electron microscopy), siRNA knockdown in HeLa cells, immunoblotting Human molecular genetics High 26085577
2021 Recruitment of the AP-5/SPG11/SPG15 complex to late endosomes/lysosomes requires coincidence detection of phosphatidylinositol 3-phosphate (PI3P) and Rag GTPases. PI3P binding is mediated by the SPG15 FYVE domain. GDP-locked RagC promotes recruitment of the complex, while GTP-locked RagA prevents its recruitment. Recruitment is enhanced in starved cells, revealing interplay between AP-5/SPG11/SPG15 and the mTORC1 pathway. Live-cell imaging and immunolocalization with PI3P manipulation, dominant-negative/constitutively active Rag GTPase expression, starvation experiments, membrane recruitment assays The Journal of cell biology High 33464297
2016 HIV-2 Gag particle release is dependent on AP-5 (and AP-3), but not AP-1 or AP-2, whereas HIV-1 Gag release requires AP-1 and AP-3 but not AP-5. This differential requirement demonstrates that AP-5 participates in an intracellular trafficking pathway used by HIV-2 Gag. siRNA knockdown of individual AP complexes combined with HIV-2/HIV-1 particle release assays PloS one Medium 27392064
2025 Bi-allelic loss-of-function variants in AP5B1 (encoding the β subunit of the AP-5 complex) cause recessive inherited macular dystrophy. Immunostaining of retinal pigment epithelium (RPE) cells shows a punctate pattern of AP5B1 staining co-localizing with markers of late endosomes and the Golgi, supporting a role for AP-5 in RPE lysosomal/endosomal homeostasis. Human genetics (whole-genome/exome sequencing), immunostaining with co-localization of late endosome and Golgi markers in RPE cells American journal of human genetics Medium 40081374
2012 AP-5 is an evolutionarily ancient heterotetrameric adaptor protein complex associated with endosomal dynamics. Its deficiency (mutations in AP5Z1) causes hereditary spastic paraplegia, implicating AP-5 in neuronal endosomal trafficking and homeostasis. Review synthesizing biochemical identification of the complex and human genetic studies Traffic (Copenhagen, Denmark) Low 23167973

Source papers

Stage 0 corpus · 30 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1986 Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology 118 2876450
2012 Adaptor protein complexes AP-4 and AP-5: new players in endosomal trafficking and progressive spastic paraplegia. Traffic (Copenhagen, Denmark) 116 23167973
2018 Role of the AP-5 adaptor protein complex in late endosome-to-Golgi retrieval. PLoS biology 99 29381698
2013 Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15. Molecular biology of the cell 98 23825025
2015 Loss of AP-5 results in accumulation of aberrant endolysosomes: defining a new type of lysosomal storage disease. Human molecular genetics 74 26085577
2003 Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5. The Journal of pharmacology and experimental therapeutics 58 14610237
1995 Neurotoxicity of dopamine and protective effects of the NMDA receptor antagonist AP-5 differ between male and female dopaminergic neurons. Experimental neurology 54 7556542
1994 Pre-emptive intrathecal administration of an NMDA receptor antagonist (AP-5) prevents hyper-reflexia in a model of persistent visceral pain. Pain 53 7936711
1992 Injection of the competitive NMDA receptor antagonist AP-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation. Neuropharmacology 49 1356250
2007 Medial prefrontal cortex infusions of bupivacaine or AP-5 block extinction of amphetamine conditioned place preference. Neurobiology of learning and memory 39 17905604
2007 When administered into the nucleus accumbens core or shell, the NMDA receptor antagonist AP-5 reinstates cocaine-seeking behavior in the rat. Neuroscience letters 36 17513051
2005 Hindbrain administration of NMDA receptor antagonist AP-5 increases food intake in the rat. American journal of physiology. Regulatory, integrative and comparative physiology 32 16269572
2006 Role of glutamate receptors in the ventromedial hypothalamus in the regulation of female rat sexual behaviors. II. Behavioral effects of selective glutamate receptor antagonists AP-5, CNQX, and DNQX. Pharmacology, biochemistry, and behavior 29 16580057
2003 Effects of intrathecal glutamatergic drugs on locomotion. II. NMDA and AP-5 in intact and late spinal cats. Journal of neurophysiology 27 12904502
2021 Rag GTPases and phosphatidylinositol 3-phosphate mediate recruitment of the AP-5/SPG11/SPG15 complex. The Journal of cell biology 25 33464297
1999 Modulation of striatal acetylcholine concentrations by NMDA and the competitive NMDA receptor-antagonist AP-5: an in vivo microdialysis study. Journal of neural transmission (Vienna, Austria : 1996) 21 10195333
1990 Differential blockade of early and late components of acoustic startle following intrathecal infusion of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) or D,L-2-amino-5-phosphonovaleric acid (AP-5). Brain research 17 1976408
2006 NMDA antagonist AP-5 increase environmentally induced cocaine-conditioned locomotion within the nucleus accumbens. Pharmacology, biochemistry, and behavior 14 16963113
2023 The structure, characterization and immunomodulatory potential of exopolysaccharide produced by Planococcus rifietoensis AP-5 from deep-sea sediments of the Northwest Pacific. International journal of biological macromolecules 12 37331538
1987 Antagonism of AP-5- and amphetamine-induced behaviour by timelotem as compared with clozapine and haloperidol. Life sciences 12 2889124
2005 Cross-talk among epidermal growth factor, Ap(5)A, and nucleotide receptors causing enhanced ATP Ca(2+) signaling involves extracellular kinase activation in cerebellar astrocytes. Journal of neuroscience research 11 16052566
1999 Noxious thermal stimulation of c-fos activity induced in rat lumbar spinal cord is reduced by AP-5 but not by glycine. Neuroscience letters 8 10027541
2016 Human Immunodeficiency Virus Type 2 (HIV-2) Gag Is Trafficked in an AP-3 and AP-5 Dependent Manner. PloS one 6 27392064
2025 Bi-allelic variants in three genes encoding distinct subunits of the vesicular AP-5 complex cause hereditary macular dystrophy. American journal of human genetics 3 40081374
1995 AP-4- and AP-5-like proteins from mouse L cells are trans-activators and bind to the GT-II region of SV40 early TRE in a mutually exclusive manner. Gene 3 7557429
2000 Effect of muscle pain and intrathecal AP-5 on electromyographic patterns during treadmill walking in the rat. Progress in neuro-psychopharmacology & biological psychiatry 2 11131178
2008 Interaction between a NMDA receptor antagonist, AP-5 and an AMPA receptor antagonist, YM 872 in antinociception in the spinal cord. Acta anaesthesiologica Scandinavica 1 18339155
2026 Bi-allelic variants in AP5Z1 and AP5B1 lead to retinal degeneration. HGG advances 0 41830174
2012 Microinjection of NMDA-type glutamate receptor agonist NMDA and antagonist D-AP-5 into the central nucleus of the amygdale alters water intake rather than food intake. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 0 22588904
1991 [The content of Ca2+ and Mg2+ ions and membrane enzyme activity (AP, 5'-NT, ATPases) in the lymphocytes infected in vitro with bovine leukemia virus]. Polskie archiwum weterynaryjne 0 1668209

Missed literature

Know a paper Affinage missed for AP5B1? Flag it for the maintainers and the community.

No submissions yet.